Stay updated on Solanezumab vs Placebo in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.

Latest updates to the Solanezumab vs Placebo in Alzheimer's Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.4 updated from v3.3.3 on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe study's site locations were updated: many new locations across the US, Australia, and Canada were added and several existing locations were removed.SummaryDifference2%

- Check51 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2, signaling a minor metadata update.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Publications section wording was updated to say publications are automatically filled in from PubMed and may not be about the study, and the revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check65 days agoChange DetectedRemoved the note about government funding status and NIH operating status from the page.SummaryDifference0.1%

- Check80 days agoChange DetectedNo significant changes detected on the page; the content and layout appear consistent with the previous state.SummaryDifference0.1%

Stay in the know with updates to Solanezumab vs Placebo in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Solanezumab vs Placebo in Alzheimer's Clinical Trial page.